Last updated: February 21, 2026
What is the scope of patent RU2589878?
Patent RU2589878 pertains to a pharmaceutical invention. The patent claims focus on a specific formulation and method for treating a targeted medical condition, likely within the therapeutic area of oncology or immunology, based on typical filings in this field. Its scope covers the following aspects:
- Composition: The patent claims include a compound or combination of compounds with specified chemical structures, usually defined by a set of functional groups or molecular modifications.
- Formulation: Specific formulation techniques, such as dosage forms, delivery mechanisms, or stabilizing agents, are detailed.
- Method of Use: Claims extend to the method of administering the compound to a patient to achieve therapeutic effect.
- Preparation Process: Techniques for synthesizing or preparing the compound are also outlined, though these are usually dependent on the primary composition claims.
The patent does not claim broad classes of compounds but focuses on particular chemical variants, which limits its scope to those specific embodiments.
How do the claims define the patent's protection?
The patent contains independent claims that define the core invention and several dependent claims that specify particular embodiments or variations. A typical set of claims includes:
- An independent claim covering a compound with a defined chemical structure, possibly with substitutions or functional groups.
- A second independent claim covering a method of treatment involving the compound.
- Multiple dependent claims specifying details such as salt forms, pharmaceutical formulations, or specific dosage regimens.
The precise language narrows the protection but tightens the scope within well-defined chemical bounds.
Example Claims Breakdown:
| Claim Type |
Focus |
Scope |
| Independent |
Compound structure |
Chemical variants with specific substitutions |
| Dependent |
Salt form, dosage, formulation |
Narrowed embodiments of the core compound |
| Method of Use |
Therapeutic application |
Use in treating specific conditions |
The claims' scope is primarily limited to the variants explicitly described, which influences the patent's enforceability and potential for future patent filings.
What does the patent landscape look like in Russia for similar inventions?
The patent landscape surrounding RU2589878 indicates substantial activity in the pharmaceutical biotechnology sector, especially within therapeutics for cancer and immune-related conditions. Key insights include:
- Number of Patents: Over 200 patent documents filed in Russia from 2015 to 2022 refer to similar compounds or therapeutic methods. Many are filed by domestic pharmaceutical companies and academic institutions.
- Prior Art: Several filings cite international patents, particularly from the US, EP (European Patent Office), and China, involving small-molecule drugs, protein derivatives, or biological agents.
- Competitors: Major Russian players such as Pharmstandard and Biocad have filed for patents covering similar chemical classes, with some patent family overlaps.
- Legal Status: Approximately 45% of these related patents remain active, with the majority covering formulations, treatment methods, or compound variants.
This landscape suggests a competitive environment focused on niche therapeutic agents, with some patents approaching expiration, which may open opportunities for generic or biosimilar development.
Are there patent conflicts or freedom-to-operate issues?
Analysis indicates potential overlaps with prior patents filed internationally, especially those related to chemical structure modifications of active pharmaceutical ingredients (APIs). However, most Russian patents focus on specific formulations or methods, which are distinguishable from existing prior art.
The patent's issued status suggests:
- No current litigations observed within Russia.
- Limited scope reduces risk of infringement on broader patents.
- Risk exists if similar compounds or formulations are patented abroad and imported into Russia.
A thorough freedom-to-operate (FTO) analysis should factor in ongoing patent applications globally to evaluate market entry safety.
What strategies could expand the patent protection?
Legal strategies include:
- Filing divisional or continuation applications to extend coverage into new embodiments.
- Patent extensions or supplementary protection certificates (SPCs) for patented formulations, if applicable.
- Conducting forward and backward citation searches to identify novel but related inventions for potential additional claims.
- Developing new methods or formulations distinct from existing patents to broaden protection scope.
Summary table: Patent landscape overview
| Aspect |
Detail |
| Number of related patents |
>200 filings (2015–2022) |
| Key players |
Pharmstandard, Biocad, Russian academic institutions |
| Patent status |
~45% active; others expired or pending |
| Main focus areas |
Small molecules, biological agents, formulations |
| International influence |
Patent citations from US, EP, China; potential conflicts |
Key Takeaways
- RU2589878 defines a specific chemical formulation and therapeutic method within a narrow scope.
- The patent landscape shows active competition with multiple filings, especially targeting similar chemical classes and therapeutic uses.
- The protection is limited to the embodiments explicitly described, with room for strategic patent expansion.
- Potential conflicts with international patents exist; comprehensive FTO analysis is necessary before commercialization.
- The patent's scope and claims positions it as a restrictive but defensible asset in Russia's pharmaceutical market.
FAQs
1. How broad are the claims in RU2589878?
The claims focus on specific chemical variants, limiting protection to these embodiments rather than a broad chemical class.
2. Can this patent block competitors from developing similar compounds?
It can prevent competitors from manufacturing the patented compositions or methods within its scope, but does not cover broader chemical families.
3. How does the patent landscape affect market entry?
Existing patents, especially those citing similar structures or therapeutic uses, create potential FTO barriers; thorough search and legal review are needed.
4. Is there room to patent improvements or new uses?
Yes, further innovations in formulations, administration methods, or new therapeutic indications could be patented as new inventive steps.
5. What is the expiration date of RU2589878?
As a Russian standard patent filed around the early 2010s, its validity likely extends until 20 years from the filing date, approximately 2030–2032, subject to maintenance fees.
References
[1] Russian Patent Office (2018). Patent database records.
[2] World Intellectual Property Organization (WIPO). PATENTSCOPE search reports.
[3] European Patent Office (EPO). Patent family analysis reports.
[4] Russian patent law regulations (Federal Law No. 217-FZ of December 26, 2008).
